Current Rating and Its Significance
MarketsMOJO’s 'Hold' rating for Viyash Scientific Ltd indicates a neutral stance on the stock, suggesting that investors should neither aggressively buy nor sell at this juncture. This rating reflects a balanced view of the company’s prospects, where certain strengths are offset by areas of caution. The 'Hold' recommendation advises investors to maintain their existing positions while monitoring the company’s developments closely.
Quality Assessment: Below Average Fundamentals
As of 06 March 2026, Viyash Scientific’s quality grade is assessed as below average. The company’s long-term fundamental strength remains weak, with an average Return on Capital Employed (ROCE) of 7.40%. This figure is modest, indicating that the company generates limited returns relative to the capital invested. Over the past five years, net sales have grown at an annual rate of 14.17%, while operating profit has increased at 12.25% per annum. Although these growth rates are positive, they are not sufficiently robust to elevate the quality grade.
Additionally, the company’s ability to service debt is a concern, with a high Debt to EBITDA ratio of 7.93 times. This elevated leverage suggests potential financial risk, especially if earnings fluctuate. Investors should be mindful of this debt burden when evaluating the company’s stability.
Valuation: Expensive but Discounted Relative to Peers
Viyash Scientific is currently rated as expensive in terms of valuation. The stock trades at an Enterprise Value to Capital Employed ratio of 7.5, which is on the higher side. However, it is important to note that this valuation is at a discount compared to the average historical valuations of its peers in the Pharmaceuticals & Biotechnology sector. This relative discount may offer some cushion for investors considering the stock.
The company’s Price/Earnings to Growth (PEG) ratio stands at 1.6, reflecting moderate expectations for future earnings growth relative to its price. Over the past year, the stock has delivered a strong return of 30.84%, supported by a remarkable 138.8% increase in profits. This profit surge underpins the current valuation and suggests that the market has priced in recent operational improvements.
Financial Trend: Outstanding Recent Performance
Financially, Viyash Scientific demonstrates an outstanding trend as of 06 March 2026. The company reported a 78.2% growth in operating profit in the December 2025 quarter, marking a continuation of positive results for eight consecutive quarters. The half-year ROCE peaked at 18.65%, a significant improvement over the long-term average, signalling enhanced capital efficiency in the near term.
Moreover, the operating profit to interest coverage ratio reached 10.49 times in the latest quarter, indicating strong earnings relative to interest expenses. The debt-equity ratio has also improved, standing at a low 0.61 times for the half-year period, which suggests a more manageable debt level compared to previous years.
Technicals: Mildly Bullish Momentum
From a technical perspective, the stock exhibits mildly bullish characteristics. The recent price movements show modest gains, with a 0.15% increase on the latest trading day and a 10.27% rise over the past six months. Shorter-term returns are mixed, with a 4.84% decline over the past week but a 1.35% gain over three months. This pattern indicates some volatility but an overall positive trend in price action.
Investors relying on technical analysis may interpret this as a signal to hold positions while awaiting clearer directional momentum.
Additional Positive Indicators: Promoter Confidence
One notable positive factor is the rising confidence of the company’s promoters. As of the latest quarter, promoters have increased their stake by 9.1%, now holding 61.43% of the company’s shares. This significant increase in promoter ownership often reflects strong belief in the company’s future prospects and can be a reassuring sign for investors.
Summary of Stock Returns
As of 06 March 2026, Viyash Scientific’s stock returns present a mixed but generally positive picture. The stock has gained 30.84% over the past year and 10.27% over six months, while shorter-term returns show slight fluctuations with a 2.79% decline year-to-date and a 4.84% drop over the past week. These figures highlight the stock’s recent resilience amid some short-term volatility.
Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!
- - Recently turned profitable
- - Strong business fundamentals
- - Pre-breakout opportunity
What This Rating Means for Investors
The 'Hold' rating on Viyash Scientific Ltd suggests that investors should maintain their current holdings rather than initiate new positions or exit existing ones. The company’s outstanding recent financial performance and rising promoter confidence provide reasons for optimism. However, the below-average quality grade and expensive valuation caution against aggressive buying.
Investors should monitor the company’s ability to sustain profit growth and manage its debt levels effectively. The mildly bullish technical indicators support a wait-and-watch approach, allowing investors to benefit from potential upside while managing risk.
Overall, the 'Hold' rating reflects a balanced view that recognises both the company’s improving fundamentals and the challenges it faces in terms of valuation and long-term quality metrics.
Sector and Market Context
Operating within the Pharmaceuticals & Biotechnology sector, Viyash Scientific is classified as a small-cap stock. This sector is known for its volatility and growth potential, driven by innovation and regulatory developments. The company’s recent profit surge and improved financial ratios position it favourably within this competitive landscape, although investors should remain vigilant given the sector’s inherent risks.
Compared to broader market benchmarks, the stock’s 30.84% return over the past year outperforms many peers, reflecting its recent operational success. However, the elevated debt levels and valuation metrics warrant careful consideration.
Conclusion
In summary, Viyash Scientific Ltd’s current 'Hold' rating by MarketsMOJO, updated on 19 Jan 2026, is supported by a combination of outstanding recent financial trends, cautious valuation, below-average quality fundamentals, and mildly bullish technical signals. Investors are advised to maintain their positions while closely monitoring the company’s ongoing performance and sector developments. The rising promoter stake adds a layer of confidence, but the company’s leverage and valuation remain key factors to watch.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
